Self guided pain therapy beat seeing a therapist, and the gap is smaller than it sounds

A large trial in the August issue of JAMA asked a question most people living with chronic pain never get to ask out loud. If you are offered a proven talking therapy for pain, does it matter whether a clinician delivers it or whether you work through it yourself at home? The answer came back on the side of home, and the more interesting part is the number sitting underneath it.

The trial ran across nine Veterans Affairs health systems and randomized 764 adults with chronic musculoskeletal pain into two groups (JAMA, 2026). One group did eleven weeks of self directed cognitive behavioral therapy for chronic pain. The other saw a clinician for four to eleven weekly sessions, under ordinary clinic conditions rather than ideal research ones. The primary measure was pain interference, which is not how much pain you feel but how much it gets in the way of walking, sleeping, working, and being with the people you like.

At four months the self directed group scored 5.26 on that scale and the clinician group 6.23, a difference of 0.98 points in favor of doing it yourself (95% confidence interval 0.65 to 1.31). The self directed group also came out ahead on every secondary measure the trial tracked, from pain intensity to sleep quality and mood, and the advantage was still visible at twelve months. They finished more of their sessions, too.

What the headline leaves out

Start with the size of the gap. The researchers set their own bar before the trial began. On this scale, a difference of one full point is the smallest change that counts as clinically important. The gap they found was 0.98, and its confidence interval runs from 0.65 to 1.31, so it straddles that bar rather than clearing it. The authors call the improvement modest, and that word is doing honest work. This is not a finding that clinicians are unnecessary. It says two real treatments landed close together, with the self directed one slightly ahead.

Then there is the phrase self directed, which is quietly misleading. Nobody in that group was handed a workbook and left alone. Every week they received a personalized audio recording of coach feedback, built from what they had reported through an automated phone check in about their pain coping, their activity and their pain ratings. The comparison was never home practice against support. It was a small, frequent, low friction kind of support set against a larger, less frequent, higher friction kind.

And then the completion finding, which I think is the actual story. The self directed group got through more of their treatment. In a field where the usual problem is not that the therapy fails but that people cannot reach it or stay with it, a format people finish is not a watered down version of care. It may be most of what produced the difference.

What I notice in practice

I want to be careful here, because this trial is not about movement and I am not going to pretend it is. Cognitive behavioral therapy for pain is a clinical treatment with its own evidence base, and nothing in this study suggests walking away from it. What crosses over is not the content. It is the finding about format.

Working as a Feldenkrais® practitioner with people who have had pain for years, the pattern I meet most often is not that they were never given good advice. It is that they have a drawer full of it. A sheet of exercises from a physiotherapist, a class they attended four times, an app they used in January. Each one was reasonable. Each one stopped. What accumulates is not simply a pile of unfinished programs but a quiet conclusion: nothing works for me. People carrying long standing back pain or widespread pain and sensitivity often arrive having drawn that conclusion several times over.

The conclusion is usually wrong, and this trial illustrates why. The people in the self directed arm were not given better material than the people sitting with a clinician. They were given a version they could complete on an ordinary Tuesday, with a small piece of human contact arriving each week to keep it honest. Adherence moved, and the outcome moved with it. You haven't lost movement so much as you've lost trust that movement will help, and every abandoned program quietly adds to that.

I see the same thing in the audio format I teach in. A lesson you can do lying on the floor with your eyes closed, without a screen and without anyone watching, asks very little of the part of you that is tired and unconvinced. That low bar is not a compromise on the practice. It is frequently the only reason the practice is still happening in week six.

What to take from it

If you are weighing a formal course of care against something you do at home, this trial does not tell you to skip the clinician. It suggests a more useful question. Not which option is stronger in principle, but which one you will still be doing in two months. If a weekly appointment across town is the thing you will quietly stop attending, a smaller daily practice may serve you better than the stronger option you abandon in week three. If the reverse is true for you, then the reverse is true.

It also argues for keeping some thread of contact rather than going it entirely alone, which is closer to what this trial tested than pure solo effort.

None of this settles what any one person should do about their pain, and a decision about a course of therapy belongs with you and your clinician. What it does clarify is something I find quietly encouraging. The distance between care that helps and care that does not is often narrower than it looks, and it runs surprisingly often through the plain question of whether the thing is small enough to keep doing. Do less, and keep it. That tends to be worth more than the better program you stopped in March.